These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34029643)

  • 41. Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer.
    Kim S; Kim SW; Bang YJ; Heo DS; Ha SW
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):414-9. PubMed ID: 12243816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disease recurrence patterns and analysis of clinicopathological prognostic factors for recurrence after resection for distal bile duct cancer.
    Choi SB; Han HJ; Park PJ; Kim WB; Song TJ; Kim JS; Suh SO; Choi SY
    Am Surg; 2015 Mar; 81(3):289-96. PubMed ID: 25760206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma.
    Nelson JW; Ghafoori AP; Willett CG; Tyler DS; Pappas TN; Clary BM; Hurwitz HI; Bendell JC; Morse MA; Clough RW; Czito BG
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):148-53. PubMed ID: 18805651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of intrapancreatic or extrapancreatic bile duct involvement on survival following pancreatoduodenectomy for common bile duct cancer.
    Kamposioras K; Anthoney A; Fernández Moro C; Cairns A; Smith AM; Liaskos C; Verbeke CS
    Br J Surg; 2014 Jan; 101(2):89-99. PubMed ID: 24375301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved oncologic outcome with chemoradiotherapy followed by surgery in unresectable intrahepatic cholangiocarcinoma.
    Cho Y; Kim TH; Seong J
    Strahlenther Onkol; 2017 Aug; 193(8):620-629. PubMed ID: 28424838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adjuvant chemoradiotherapy instead of revision radical resection after local excision for high-risk early rectal cancer.
    Jeong JU; Nam TK; Kim HR; Shim HJ; Kim YH; Yoon MS; Song JY; Ahn SJ; Chung WK
    Radiat Oncol; 2016 Sep; 11(1):114. PubMed ID: 27595767
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Salvage radiotherapy for locoregionally recurrent extrahepatic bile duct cancer after radical surgery.
    Kim E; Kim YJ; Kim K; Song C; Kim JS; Oh DY; Nam EM; Chie EK
    Br J Radiol; 2017 Dec; 90(1080):20170308. PubMed ID: 28937265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
    Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Comparison of Inflammation-Based Prognostic Scores in Patients With Extrahepatic Bile Duct Cancer After Pancreaticoduodenectomy.
    Fujiwara Y; Haruki K; Shiba H; Hamura R; Shirai Y; Furukawa K; Gocho T; Yanaga K
    J Surg Res; 2019 Jun; 238():102-112. PubMed ID: 30769246
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.
    Ecker BL; Vining CC; Roses RE; Maggino L; Lee MK; Drebin JA; Fraker DL; Vollmer CM; Datta J
    Ann Surg Oncol; 2017 Dec; 24(13):3926-3933. PubMed ID: 28952140
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative Outcomes of Preoperative Chemoradiotherapy and Selective Postoperative Chemoradiotherapy in Clinical Stage T3N0 Low and Mid Rectal Cancer.
    Lin Y; Lin H; Xu Z; Zhou S; Chi P
    J Invest Surg; 2019 Nov; 32(7):679-687. PubMed ID: 30215538
    [No Abstract]   [Full Text] [Related]  

  • 53. MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma.
    Tamada S; Shibahara H; Higashi M; Goto M; Batra SK; Imai K; Yonezawa S
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4257-64. PubMed ID: 16857800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of Prognostic Factors and the Efficacy of Adjuvant S-1 Chemotherapy in Patients with Post-surgery Extrahepatic Bile Duct Cancer.
    Okabayashi T; Shima Y; Iwata J; Morita S; Sumiyoshi T; Sui K; Shimada Y; Iiyama T
    Anticancer Res; 2017 Dec; 37(12):7049-7056. PubMed ID: 29187494
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of adjuvant radiotherapy in microscopic tumor control after extrahepatic bile duct cancer surgery.
    Oh D; Lim DH; Heo JS; Choi SH; Choi DW; Ahn YC; Park W; Huh SJ
    Am J Clin Oncol; 2007 Feb; 30(1):21-5. PubMed ID: 17278890
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patterns of failure after resection of extrahepatic bile duct cancer: implications for adjuvant radiotherapy indication and treatment volumes.
    Choi HS; Kang KM; Jeong BK; Jeong H; Lee YH; Ha IB; Kim TG; Song JH
    Radiat Oncol; 2018 May; 13(1):85. PubMed ID: 29739420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma.
    Im JH; Choi GH; Lee WJ; Han DH; Park SW; Bang S; Choi HJ; Seong J
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2435-2445. PubMed ID: 33471185
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preoperative cholangitis and metastatic lymph node have a negative impact on survival after resection of extrahepatic bile duct cancer.
    Cho JY; Han HS; Yoon YS; Hwang DW; Jung K; Kim JH; Kwon Y; Kim H
    World J Surg; 2012 Aug; 36(8):1842-7. PubMed ID: 22526039
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy.
    Zhang LN; Xiao WW; Xi SY; OuYang PY; You KY; Zeng ZF; Ding PR; Zhang HZ; Pan ZZ; Xu RH; Gao YH
    Oncotarget; 2016 Feb; 7(5):6335-44. PubMed ID: 26695441
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of Adjuvant Chemoradiotherapy for Duodenal Cancer: An Updated Analysis of Long-Term Follow-Up from Single Institution.
    Jang BS; Park HJ; Kim K; Jang JY; Kim SW; Oh DY; Chie EK
    World J Surg; 2018 Oct; 42(10):3294-3301. PubMed ID: 29869181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.